Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia

Molecular Biology Reports

Volumn 41, Issue 1, 2014, Pages 95-103

  Rana, Sobia ^a   Munawar, Mustafa ^a   Shahid, Adeela ^a   Malik, Meera ^a   Ullah, Hafeez ^a   Fatima, Warda ^b   Mohsin, Shahida ^a   Mahmood, Saqib ^a  

^a UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

Chronic lymphocytic leukemia; Circadian clock; Clock genes; Clock controlled genes; Melatonin; Shift work

Indexed keywords

CYCLIN D1; MELATONIN; MESSENGER RNA; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BMAL1 GENE; CANCER GENETICS; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CIRCADIAN CLOCK GENE; CLINICAL ARTICLE; CLOCK CONTROLLED CELL CYCLE GENE; CLOCK GENE; CONTROLLED STUDY; CYCLIN D1 GENE; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC DISORDER; HORMONE BLOOD LEVEL; HUMAN; LEUKEMOGENESIS; MALE; MELATONIN BLOOD LEVEL; MIDDLE AGED; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; PER1 GENE; PER2 GENE; SHIFT WORKER; UPREGULATION; VERY ELDERLY; WEE1 GENE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM SIGNALING PEPTIDES AND PROTEINS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MELATONIN; MIDDLE AGED; TRANSCRIPTION, GENETIC;

EID: 84891945122     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2841-7     Document Type: Article

References (44)

1. Reppert SM, Weaver DR (2002) Coordination of circadian timing in mammals. Nature 418:935-941
2. Hastings MH, Reddy AB, Maywood ES (2003) A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 4:649-661
3. Geyfman M, Andersen B (2009) How the skin can tell time. J Invest Dermatol 129:1063-1066
4. Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves I, Zheng B, Kume K, Lee CC, van der Horst GT, Hastings MH, Reppert SM (2000) Interacting molecular loops in the mammalian circadian clock. Science 288:1013-1019
5. Takahashi JS (2004) Finding new clock components: past and future. J Biol Rhythms 19:339-347
6. Fu L, Lee CC (2003) The circadian clock: pacemaker and tumor suppressor. Nat Rev Cancer 3:350-361
7. Duffield GE (2003) DNA microarray analyses of circadian timing: the genomic basis of biological time. J Neuroendocrinol 15:991-1002
8. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302:255-259
9. Fu L, Pelicano H, Liu J, Huang P, Lee C (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41-50
10. Döhner H, Stilgenbauer K, Döhner M (1999) Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 77:266-281
11. Caligaris-Cappio F, Hamblin TJ (1999) B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 17:399-408
12. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408
13. Smith A, Howell D, Patmore R (2011) Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 105:1684-1692
14. Sgambati M, Linet MS, Devesa SS (2001) Chronic lymphocytic leukemia epidemiological, familial, and genetic aspects. In: Cheson BD (ed) Chronic lymphoid leukemia s basic and clinical oncology. Marcel Dekker, New York, pp 33-62
15. Takahashi JS, Hong HK, Ko CH, McDearmon EL (2008) The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 9:764-775
16. Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HY, Liu TC, Hsiao HH, Liu YC, Lin SF (2006) Down-regulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci 97:1298-1307
17. Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY (2012) Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol 33:149-155
18. Eisele L, Prinz R, Klein-Hitpass L, Nückel H, Lowinski K, Thomale J, Moeller LC, Dührsen U, Dürig J (2009) Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia. Eur J Haematol 83:320-327
19. Mostafaie N, Kállay E, Sauerzapf E, Bonner E, Kriwanek S, Cross HS, Huber KR, Krugluger W (2009) Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer. Mol Carcinog 48:642-647
20. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274
21. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP (2006) The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 22:375-382
22. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen Guillaume G, Halberg F (2006) Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 97:589-596
23. Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP (2005) Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 106:2827-2836
24. Yang X, Wood PA, Ansell C, Hrushesky WJ (2009) Circadian time-dependent tumor suppressor function of period genes. Integr Cancer Ther 8:309-316
25. Liao DJ, Thakur A, Wu J, Biliran H, Sarkar FH (2007) Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. Crit Rev Oncog 13:93-158
26. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F (2006) The c-Myc target gene network. Semin Cancer Biol 16:253-264
27. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG (2004) Mini-review: Cyclind1: normal and abnormal functions. Endocrinology 145:5439-5447
28. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39-85
29. Backert S, Gelos M, Kobalz U, Hanski ML, Böhm C, Mann B, Lövin N, Gratchev A, Mansmann U, Moyer MP, Riecken EO, Hanski C (1999) Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array. Int J Cancer 82:868-874
30. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H (2004) The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol 15:252-256
31. Mateyak MK, Obaya AJ, Sedivy JM (1999) C-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 19:4672-4683
32. Marhin WW, Hei YJ, Chen S, Jiang Z, Gallie BL, Phillips RA, Penn LZ (1996) Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation. Oncogene 12:43-52
33. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G (2005) The molecular clock mediates leptin-regulated bone formation. Cell 122:803-815
34. Zeng ZL, Wu MW, Sun J, Sun YL, Cai YC, Huang YJ, Xian LJ (2010) Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity. J Biochem 148:319-326
35. Taniguchi H, Fernández AF, Setién F, Ropero S, Ballestar E, Villanueva A, Yamamoto H, Imai K, Shinomura Y, Esteller M (2009) Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res 69:8447-8454
36. Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J, Zhu Y (2010) CLOCK in breast tumorigenesis: evidence from genetic, epigenetic, and transcriptional profiling analyses. Cancer Res 70:1459-1468
37. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8:1065-1066
38. Viswanathan AN, Hankinson SE, Schernhammer ES (2007) Night shift work and the risk of endometrial cancer. Cancer Res 67:10618-10622
39. Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, Miki T, Nakao M, Hayashi K, Suzuki K, Mori M, Washio M, Sakauchi F, Ito Y, Yoshimura T, Tamakoshi A (2006) Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 164:549-555
40. Conlon M, Lightfoot N, Kreiger N (2007) Rotating shift work and risk of prostate cancer. Epidemiology 18:182-183
41. Lahti TA, Partonen T, Kyyrönen P, Kauppinen T, Pukkala E (2008) Night-time work predisposes to non-Hodgkin lymphoma. Int J Cancer 123:2148-2151
42. Mirick DK, Davis S (2008) Melatonin as a biomarker of circadian dysregulation. Cancer Epidemiol Biomarkers Prev 17:3306-3313
43. Bartsch C, Bartsch H, Schmidt A, Ilg S, Bichler KH, Flüchter SH (1992) Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations. Clin Chim Acta 209:153-167
44. Schernhammer ES, Hankinson SE (2009) Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Cancer Epidemiol Biomarkers Prev 18:74-79